2025 annual financial data
CytoMed Therapeutics 2025 Financial results
Direct answer
Revenue was 319,201 SGD.
Operating income was -4,519,770 SGD and net income was -3,916,834 SGD.
Operating cash flow was -3,697,463 SGD.
Get free CytoMed Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 319,201 SGD
- Operating income
- -4,519,770 SGD
- Net income
- -3,916,834 SGD
- Operating cash flow
- -3,697,463 SGD
Explore related company data
View all 2025 financial metricsView RevenueView Operating incomeView Net incomeView Operating cash flowView Revenue growthView Operating income growthView Net income growthView Operating cash flow growthView Operating marginView Net marginView Operating cash flow marginView all CytoMed Therapeutics financial years